|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
in00000295766 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
131002s1998 gw a ob 001 0 ger d |
005 |
20240703151433.4 |
019 |
|
|
|a 922947756
|a 1055385061
|a 1065943549
|a 1081195720
|
020 |
|
|
|a 9783110807271
|q (electronic bk.)
|
020 |
|
|
|a 3110807270
|q (electronic bk.)
|
020 |
|
|
|z 3110161591
|
020 |
|
|
|z 9783110161595
|
029 |
1 |
|
|a DEBBG
|b BV044053704
|
035 |
|
|
|a (OCoLC)859262995
|z (OCoLC)922947756
|z (OCoLC)1055385061
|z (OCoLC)1065943549
|z (OCoLC)1081195720
|
035 |
|
|
|a (OCoLC)ocn859262995
|
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OCLCO
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d ZCU
|d MERUC
|d OCLCQ
|d OCLCO
|d DEGRU
|d OCLCA
|d UIU
|d ICG
|d OCLCA
|d VT2
|d OCLCQ
|d WYU
|d OCLCA
|d DKC
|d OCLCQ
|d UKAHL
|d UX1
|d OCLCQ
|d BRF
|d INARC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|
050 |
|
4 |
|a RC280.P7
|b M65 1998eb
|
060 |
|
4 |
|a 1998 I-042
|
060 |
|
4 |
|a WJ 752
|b M718 1998
|
066 |
|
|
|c (S
|
072 |
|
7 |
|a RC
|2 lcco
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/463
|2 23
|
084 |
|
|
|a XH 8017
|2 rvk
|
245 |
0 |
0 |
|a Molecular biology of prostate cancer /
|c editors, M. Wirth [and others].
|
264 |
|
1 |
|a Berlin ;
|a New York :
|b Walter de Gruyter,
|c 1998.
|
300 |
|
|
|a 1 online resource (x, 208 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Frontmatter --
|t Preface --
|t Contents --
|t List of first-mentioned contributors --
|t Cytogenetic alterations in prostate cancer /
|r Sauter, G. --
|t The regulation of prostatic growth /
|r Griffiths, K. --
|t Current concepts of oncogenes in prostate cancer /
|r Peehl, D. M. --
|t Tumour suppressor genes in prostate cancer /
|r Brewster, S. F. --
|t The use of differential display PCR for the detection of new tumor suppressor genes in prostate cancer /
|r Pilarsky, Ch. P. --
|t Molecular alterations associated with prostate cancer development /
|r Bussemakers, M. J. G. / Schalken, J. A. --
|t Dysfunction of the cell-cell adhesion complex in lethal prostate cancer /
|r Paul, R. / Isaacs, W. B. / Bova, G. S. --
|t Heparan sulfate proteoglycans and prostate cancer: a conceptual framework /
|r Schamhart, D. H. J. / Kurth, K.-H. --
|t Androgen receptor mutations in prostate cancer /
|r Klocker, H. / Culig, Z. / Hobisch, A. / Hittmair, A. / Bartsch, G. / Peterziel, H. / Cato, A. C. B. --
|t Antiandrogen binding to androgen receptors and the consequences /
|r Furr, B. J. A. --
|t Expression of the MDR1 gene in prostate carcinoma /
|r Siegsmund, M. J. / Schummer, B. / Steidler, A. / Greschner, M. / Köhrmann, K.-U. / Alken, P. --
|t Human prostate cancer progression models and therapeutic intervention /
|r Chung, L. W. K. / Kao, C. / Sikes, R. A. / Zhau, H. E. --
|t Tumor angiogenesis: the VEGF signalling system is a novel target for prostate cancer therapy /
|r Marmé, D. --
|t Antimetastatic approaches to therapy of prostate cancer /
|r Heicappell, R. --
|t Intermittent androgen suppression: rationale and clinical experience /
|r Gleave, M. / Bruchovsky, N. / Goldenberg, S. L. / Rennie, P. --
|t Resistance to drug therapy in cancer: gene therapy approaches to overcome anticancer drug resistance /
|r Licht, Th. --
|t PSA RT-PCR: current status and future potential /
|r Ellis, W. J. / Vessella, R. L. / Melchior, S. W. / Lange, P. H. --
|t Special aspects of PSMA and PSA RT-PCR for the detection of disseminated prostate cells /
|r Schmidt, B. / Bendhack, M. / Ackermann, R. / Schmitz-Dräger, B. J. --
|t Molecular forms of PSA, PSA density, age-/racespecific reference ranges, and PSA velocity /
|r Beduschi, M. C. / Beduschi, R. / Oesterling, J. E. --
|t Reverse transcriptase-polymerase chain reaction assays used for molecular staging of prostate cancer patients /
|r Olsson, C. A. / Buttyan, R. --
|t Concluding remarks /
|r Altwein, J. E.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Prostate
|x Cancer
|x Molecular aspects.
|
650 |
|
0 |
|a Prostate
|x Cancer
|x Treatment.
|
650 |
1 |
2 |
|a Prostatic Neoplasms
|x genetics
|
650 |
2 |
2 |
|a Prostatic Neoplasms
|x therapy
|
700 |
1 |
|
|a Wirth, M.
|
776 |
0 |
8 |
|i Print version:
|t Molecular biology of prostate cancer
|z 9783110161595
|w (OCoLC)39931134
|
852 |
|
|
|b E-Collections
|h ProQuest
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3044476
|z Full text (MCPHS users only)
|t 0
|
880 |
0 |
0 |
|6 505-00/(S
|t Frontmatter --
|t Preface --
|t Contents --
|t List of first-mentioned contributors --
|t Cytogenetic alterations in prostate cancer /
|r Sauter, G. --
|t The regulation of prostatic growth /
|r Griffiths, K. --
|t Current concepts of oncogenes in prostate cancer /
|r Peehl, D.M. --
|t Tumour suppressor genes in prostate cancer /
|r Brewster, S.F. --
|t The use of differential display PCR for the detection of new tumor suppressor genes in prostate cancer /
|r Pilarsky, Ch. P. --
|t Molecular alterations associated with prostate cancer development /
|r Bussemakers, M.J.G. ; Schalken, J.A. --
|t Dysfunction of the cell-cell adhesion complex in lethal prostate cancer /
|r Paul, R. ; Isaacs, W.B. ; Bova, G.S. --
|t Heparan sulfate proteoglycans and prostate cancer: a conceptual framework /
|r Schamhart, D.H.J. ; Kurth, K.-H. --
|t Androgen receptor mutations in prostate cancer /
|r Klocker, H. ; Culig, Z. ; Hobisch, A. ; Hittmair, A. ; Bartsch, G. ; Peterziel, H. ; Cato, A.C. Β. --
|t Antiandrogen binding to androgen receptors and the consequences /
|r Furr, B.J.A. --
|t Expression of the MDR1 gene in prostate carcinoma /
|r Siegsmund, M.J. ; Schummer, Β. ; Steidler, A. ; Greschner, M. ; Köhrmann, K.-U. ; Alken, P. --
|t Human prostate cancer progression models and therapeutic intervention /
|r Chung, L.W.K. ; Kao, C. ; Sikes, R.A. ; Zhau, H.E. --
|t Tumor angiogenesis: the VEGF signalling system is a novel target for prostate cancer therapy /
|r Marmé, D. --
|t Antimetastatic approaches to therapy of prostate cancer /
|r Heicappell, R. --
|t Intermittent androgen suppression: rationale and clinical experience /
|r Gleave, M. ; Bruchovsky, N. ; Goldenberg, S.L. ; Rennie, P. --
|t Resistance to drug therapy in cancer: gene therapy approaches to overcome anticancer drug resistance /
|r Licht, Th. --
|t PSA RT-PCR: current status and future potential /
|r Ellis, W.J. ; Vessella, R.L. ; Melchior, S.W. ; Lange, P.H. --
|t Special aspects of PSMA and PSA RT-PCR for the detection of disseminated prostate cells /
|r Schmidt, B. ; Bendhack, M. ; Ackermann, R. ; Schmitz-Dräger, Β. J. --
|t Molecular forms of PSA, PSA density, age-/racespecific reference ranges, and PSA velocity /
|r Beduschi, M.C. ; Beduschi, R. ; Oesterling, J.E. --
|t Reverse transcriptase-polymerase chain reaction assays used for molecular staging of prostate cancer patients /
|r Olsson, C.A. ; Buttyan, R. --
|t Concluding remarks /
|r Altwein, J.E.
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10819188
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 627726
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3044476
|
938 |
|
|
|a De Gruyter
|b DEGR
|n 9783110807271
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH25316452
|
938 |
|
|
|a Internet Archive
|b INAR
|n molecularbiology0000unse_z2y0
|
947 |
|
|
|a FLO
|x pq-ebc-base
|
999 |
f |
f |
|s f7a7c3cd-0869-4eb7-94cb-d8925c8c67f2
|i d05c4a17-3545-47dc-a61b-a990cd760e8d
|t 0
|
952 |
f |
f |
|a Massachusetts College of Pharmacy and Health Sciences
|b Online
|c Online
|d E-Collections
|t 0
|e ProQuest
|h Other scheme
|
856 |
4 |
0 |
|t 0
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3044476
|y Full text (MCPHS users only)
|